NPPA computed the Retail Price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (as extended release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Micro Labs Ltd. (Marketer)

Mar 01, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Compliance

The National Pharmaceutical Pricing Authority (NPPA) on February 27, 2025, issued the Computation of Retail Price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (as extended release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Micro Labs Ltd. (Marketer).

The following has been stated namely: -

• The Retail Price has been computed based on the data from June, 2024

• The Retail Price has been computed for Each Film Coated Tablet Containing Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (as extended release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Micro Labs Ltd. (Marketer)

• The Total MAT is 33,47,73,027

[Notification No. 19(4212)/2024/DP/NPPA/DIV.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT